BRIEF published on 03/06/2026 at 10:41, 17 days ago Eckert & Ziegler propose un dividende de 0,22 € par action pour 2025 Assemblée Générale Annuelle Relations Avec Les Investisseurs Proposition De Dividende Exercice Financier 2025 Eckert Et Ziegler
BRIEF published on 03/06/2026 at 10:41, 17 days ago Eckert & Ziegler Proposes €0.22 Dividend per Share for 2025 Annual General Meeting Investor Relations Eckert & Ziegler Dividend Proposal Financial Year 2025
PRESS RELEASE published on 03/06/2026 at 10:36, 17 days 1 hour ago EQS-Adhoc: Eckert & Ziegler Plans Dividend of € 0.22 per Share for 2025 Eckert & Ziegler SE plans dividend of €0.22 per share for 2025, subject to AGM approval. Detailed financial statements to be released on March 26, 2026 Shareholders Annual Financial Statements Dividend Eckert & Ziegler SE 2025 Financial Year
BRIEF published on 02/26/2026 at 07:05, 25 days 4 hours ago Eckert & Ziegler s'associe à Molecular Partners pour le développement de Radio-DARPin Partenariat Traitement Du Cancer Produits Radiopharmaceutiques Eckert Et Ziegler Radio-DARPin
BRIEF published on 02/26/2026 at 07:05, 25 days 4 hours ago Eckert & Ziegler Partners with Molecular Partners for Radio-DARPin Development Partnership Cancer Treatment Eckert & Ziegler Radiopharmaceuticals Radio-DARPin
PRESS RELEASE published on 02/26/2026 at 07:00, 25 days 4 hours ago Eckert & Ziegler Enters Partnership with Molecular Partners to Support Development of Radio-DARPin Therapeutics Eckert & Ziegler SE partners with Molecular Partners to develop Radio-DARPin therapeutics, leveraging DARPin technology for cancer treatment with alpha emitters Partnership Eckert & Ziegler Therapeutics Radio-DARPin Molecular Partners
BRIEF published on 02/16/2026 at 11:05, 1 month 7 days ago Eckert & Ziegler and UJF Boost Actinium-225 Production Eckert & Ziegler Radiopharmaceuticals Production Increase Actinium-225 Global Supply
BRIEF published on 02/16/2026 at 11:05, 1 month 7 days ago Eckert & Ziegler et l'UJF stimulent la production d'actinium-225 Produits Radiopharmaceutiques Augmentation De La Production Actinium-225 Approvisionnement Mondial Eckert Et Ziegler
PRESS RELEASE published on 02/16/2026 at 11:00, 1 month 7 days ago Eckert & Ziegler and UJF Significantly Increase Production Volume for Actinium-225 Eckert & Ziegler SE and UJF increase Actinium-225 production volume, addressing global demand for alpha-emitting radionuclides in targeted radiopharmaceutical applications Eckert & Ziegler Production Volume Radiopharmaceuticals Actinium-225 UJF
BRIEF published on 02/05/2026 at 09:05, 1 month 18 days ago Eckert & Ziegler SE: Steady Growth and Strategic Positioning Financial Results Market Expansion Nuclear Medicine Radioisotopes Therapeutic Isotopes
Published on 03/23/2026 at 11:30, 10 minutes ago Trans Canada Gold Provides Update on Non-Brokered Private Placement and Flow-through Private Placement for Drilling at the Harrison Lake District Scale Gold Property Acquisition
Published on 03/23/2026 at 08:00, 3 hours 40 minutes ago ABRIDGED, PRELIMINARY AND UNAUDITED QUARTERLY AND FULL YEAR RESULTS AND DETAILS OF MANAGEMENT CONFERENCE Call for the Fourth Quarter and Full Year Ended December 31, 2025 ("The Quarter" or "Q4 2025" and "FY 2025" Respectively)
Published on 03/23/2026 at 02:00, 9 hours 40 minutes ago FutureGen Industries Announces Open Market Investments
Published on 03/23/2026 at 11:30, 10 minutes ago EQS Group lance un module de gestion des risques pour faciliter la surveillance continue des risques liées aux données et à l’IA
Published on 03/23/2026 at 11:06, 33 minutes ago Aroundtown SA: Release of a capital market information
Published on 03/23/2026 at 11:05, 35 minutes ago ASUS Unveils Complete Portfolio Support for Intel® Core™ 200S Series
Published on 03/23/2026 at 11:05, 35 minutes ago BRAIN Biotech has been granted a key patent for its CRISPR-BMC genome-editing technology
Published on 03/23/2026 at 10:30, 1 hour 10 minutes ago TK Elevator appoints Brad Selleck as Chief Operating Officer; Vincent Della Valle to retire
Published on 03/23/2026 at 08:10, 3 hours 30 minutes ago Entrée en négociations exclusives de cession de la participation dans Winncare
Published on 03/20/2026 at 19:00, 2 days 16 hours ago AXA - Conditions for availability or consultation of information relating to AXA’s Shareholders’ Meeting of April 30, 2026
Published on 03/20/2026 at 19:00, 2 days 16 hours ago AXA - Modalités de mise à disposition ou de consultation des informations relatives à l’Assemblée Générale du 30 avril 2026
Published on 03/20/2026 at 18:15, 2 days 17 hours ago Publication of AXA’s 2025 Universal Registration Document
Published on 03/20/2026 at 18:15, 2 days 17 hours ago Mise à disposition du Document d’Enregistrement Universel 2025 d’AXA
